- JP-listed companies
- SATO PHARMACEUTICAL CO.,LTD.
- Income statement
SATO PHARMACEUTICAL CO.,LTD.【JP:E00954】Income statement
Market cap
P/E ratio
| 2011/07 | 2012/07 | 2013/07 | 2014/07 | 2015/07 | 2016/07 | 2017/07 | 2018/07 | 2019/07 | 2020/07 | 2021/07 | 2022/07 | 2023/07 | |
| Revenue | 35,328 | 36,522 | 38,113 | 38,804 | 38,729 | 38,898 | 39,467 | 41,688 | 45,715 | 45,873 | 43,151 | 44,492 | 47,915 |
| Cost of revenue | - | - | - | 13,509 | 13,833 | 14,327 | 15,043 | 16,400 | 17,851 | 18,687 | 18,099 | 19,215 | 20,515 |
| Gross profit | - | - | - | 25,294 | 24,895 | 24,570 | 24,424 | 25,287 | 27,864 | 27,186 | 25,051 | 25,277 | 27,400 |
| Gross margin (%) | - | - | - | ||||||||||
| Operating expenses | - | - | - | 23,007 | 23,611 | 23,977 | 24,452 | 24,263 | 25,124 | 24,966 | 24,365 | 24,320 | 24,562 |
| Operating income | - | - | - | 2,336 | 1,255 | 624 | 4 | 1,230 | 2,774 | 2,221 | 695 | 956 | 2,837 |
| Income before tax | 2,439 | 3,124 | 3,803 | 2,732 | 2,034 | 37 | -21 | 1,326 | 2,670 | 2,157 | 755 | 1,068 | 2,936 |
| Provision for income taxes | - | - | - | 844 | 862 | 298 | 106 | 562 | 851 | 831 | 323 | 397 | 817 |
| Net income | 1,454 | 1,437 | 2,461 | 1,857 | 1,156 | -263 | -355 | 852 | 2,004 | 1,887 | 547 | 743 | 1,965 |
| Earnings per share | 286.21 | 283.65 | 487.45 | 368.97 | 230.41 | -52.67 | -71.36 | 171.6 | 405.01 | 382.13 | 110.83 | 150.84 | 399.18 |
| Dividend per share | 20 | 20 | 20 | 20 | 30 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |